SiO 2 ‐CaO CME /Poly(Tetrahydrofuran)/Poly(Caprolactone) 3D‐Printed Scaffolds Drive Human‐Bone Marrow Stromal Cell Osteogenic Differentiation
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202503733 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von David R Sory und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Heart and Lung Institute, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Osteogenesis, Tissue Scaffolds, Polyesters, Mesenchymal Stem Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EPSRC, National Heart and Lung Institute at Imperial College London, BBSRC.
Abstract (Originalsprache)
This article addresses the unmet clinical need of scaffolds for bone regeneration that can combine osteogenic properties, such as the promotion of bone marrow stem cell differentiation into osteoblasts, with the ability to withstand cyclic loading. In our previous study, we demonstrated that discs of SiO 2 ‐CaO CME /poly(tetrahydrofuran)/poly(caprolactone) hybrids or their dissolution products can drive terminal osteogenic differentiation of human bone marrow stromal cells (h‐BMSCs) in vitro. The current study shows that the 3D‐printed hybrid scaffolds with physiologically relevant 3D architecture further promote h‐BMSC osteogenesis. The 3D‐printed scaffolds support spatially organized cell behavior in an environment mirroring conditions relevant to off‐the‐shelf implant applications. Primary cellular functions, including viability, adhesion, and proliferation, were maintained across 3D scaffold surfaces and within inter‐strut regions. osteogenic commitment was evidenced by the upregulation of lineage‐specific transcripts, hydroxyapatite deposition, and the organized assembly of extracellular matrix (ECM) proteins. Our results demonstrate that 3D‐printed scaffolds drive osteogenesis by modulating cell metabolism, inducing osteogenic morphological transitions, and promoting the expression of osteocalcin and collagen type I alpha 1 chain, alongside hydroxyapatite matrix mineralization. Collectively, our findings highlight the SiO 2 ‐CaO CME /poly(tetrahydrofuran)/poly(caprolactone) scaffold's strong osteogenic properties—driven by composition, surface architecture, and ion release – and its promise for clinical bone regeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Heart and Lung Institute, Imperial College London, London, UK.
- Department of Materials, Imperial College London, London, UK.
ORCID-Profile: David R Sory, Agathe C M Heyraud, Julian R Jones, Sara M Rankin
Förderung
- EPSRC
- National Heart and Lung Institute at Imperial College London
- BBSRC
- Wellcome Trust
- Engineering and Physical Sciences Research Council
- Biotechnology and Biological Sciences Research Council
Zitieren
APA
Sory, D. R., Heyraud, A. C. M., Jones, J. R., & Rankin, S. M. (2026). SiO 2 ‐CaO CME /Poly(Tetrahydrofuran)/Poly(Caprolactone) 3D‐Printed Scaffolds Drive Human‐Bone Marrow Stromal Cell Osteogenic Differentiation. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202503733
Vancouver
Sory DR, Heyraud ACM, Jones JR, Rankin SM. SiO 2 ‐CaO CME /Poly(Tetrahydrofuran)/Poly(Caprolactone) 3D‐Printed Scaffolds Drive Human‐Bone Marrow Stromal Cell Osteogenic Differentiation. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202503733
BibTeX
@article{Sory2026,
author = {Sory, David R and Heyraud, Agathe C M and Jones, Julian R and Rankin, Sara M},
title = {SiO 2 ‐CaO CME /Poly(Tetrahydrofuran)/Poly(Caprolactone) 3D‐Printed Scaffolds Drive Human‐Bone Marrow Stromal Cell Osteogenic Differentiation},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202503733}
}
EUVIMED